RI Research Instruments Awarded $7.7M Linear Accelerator Contract from DoE Brookhaven National Laboratory
News Apr 23, 2010
RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies (BEST), Inc., has announced the award of a $7.7 million contract from the U.S. Department of Energy's Brookhaven National Laboratory. The contract is for the turn-key supply of a 200 MeV electron injection linear accelerator for BNL's next-generation National Synchrotron Light Source (NSLS-II).
This new contract covers the engineering, manufacturing, integration, delivery, installation and commissioning of the linear accelerator (linac). Delivery is expected in January 2012. A linac represents the first key element of third generation synchrotron light sources. It generates, accelerates and delivers an electron beam of superior quality to be used in a storage ring for generating x-rays, ultraviolet light and infrared light for research in such diverse fields as biology and medicine, chemistry and environmental sciences, physics, and materials science.
According to a BNL publication, their current light source - the National Synchrotron Light Source (NSLS). Meeting the critical scientific challenges of the United States energy future will require advanced new capabilities that a new facility called NSLS-II is expected to provide. Construction of the NSLS-II began in 2009 and initial operation is expected in 2015.
NSLS-II will be a new medium-energy electron storage ring (3 billion electron-volts) designed to deliver intensity and brightness, and produce x-rays more than 10,000 times brighter than the current NSLS.
Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes SynthesisNews
TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.READ MORE
Cancer Fighting Compound Activated by Substance Found in Stinging NettlesNews
Researchers have developed a new line of attack against cancer: an organic-osmium compound, which is triggered using a non-toxic dose of sodium formate, a natural product found in many organisms, including nettles and ants.READ MORE